Full text is available at the source.
Abstract
Rapamycin is recognized for its potential to extend lifespan.
- Atrial fibrillation (AF) is linked to aging and poses significant health risks.
- The effects of rapamycin on age-related changes in heart tissue and AF risk are not well understood.
- Understanding how rapamycin influences atrial remodeling could help address AF susceptibility.
Simplified